AEF0117 THC Interaction Trial Withdrawn: Implications for Selective CB1 Modulation
The withdrawal of the AEF0117 trial delays progress in selective CB1 receptor modulation for managing THC-related effects. This setback impacts potential pharmacological treatments for cannabis use disorder. Clinicians and patients face longer timelines…
Cannabis Use, Anxiety, and Depression Trends in Canada
Recent research highlights rising cannabis use alongside increased anxiety and depression in Canada. Cannabis use and mental health risks are complex, with high-THC products potentially worsening symptoms. Patients should seek medical guidance on…
Marijuana Use & Dangers for Adolescents & Young Adults
Marijuana use adolescent mental health risks are significant due to the brain's ongoing development into the mid-twenties. Regular cannabis use during adolescence can accelerate mental health problems requiring professional care. Understanding these…
Understanding Cannabinoid Hyperemesis Syndrome in Chronic Cannabis Users
Cannabinoid hyperemesis syndrome clinical overview reveals a paradoxical condition affecting chronic cannabis users. It causes severe nausea and vomiting, often temporarily relieved by hot showers. Understanding this syndrome is crucial for proper…
Recall Issued on Multiple Adult-Use Cannabis Products Tested by Keystone
A keystone laboratory cannabis recall has been issued for multiple adult-use products in New York. This recall addresses potential contamination and safety risks in regulated cannabis markets. Consumers should verify product safety with dispensaries to…
OCM Issues Precautionary Recall for Keystone Lab Cannabis Products
The New York Office of Cannabis Management issued a precautionary cannabis recall for select products tested by Keystone Lab. This recall highlights concerns about cannabis product safety and testing accuracy. Patients should verify their products…
Does Cannabis Cause Judgment Impairment and Increase Manipulation Risk?
Cannabis judgment impairment is a critical concern for patients using THC. High doses of THC can disrupt executive function and increase vulnerability to social influence. Understanding cannabis judgment impairment helps patients make safer choices.
Rare Cannabinoid Company Expands Mood Collection with New CBC Gummies
CBC gummies mood support offers patients a new THC-free cannabinoid option with potential mood-related benefits. While commercially available, clinical evidence remains limited and dosing guidelines are not established. Patients should approach CBC…
Modulating the Endocannabinoid System in Alcohol Use Disorder: A Translational Systematic Review
ECS modulation alcohol use disorder offers a novel approach targeting neurobiological mechanisms of craving and relapse. This translational review highlights cannabinoid receptor roles in alcohol dependence. ECS-targeted therapies may expand options for…
Study uncovers another reason not to skimp on sleep – ASU News
Sleep deprivation impulsivity cannabis interactions can worsen substance use behaviors. Patients using cannabis for sleep should understand this risk. Poor sleep impairs decision-making and increases impulsivity.